[Federal Register Volume 87, Number 213 (Friday, November 4, 2022)]
[Notices]
[Page 66705]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-24016]


-----------------------------------------------------------------------

FEDERAL TRADE COMMISSION

[File No. P222100]


HISA Anti-Doping and Medication Control Rule; Correction

AGENCY: Federal Trade Commission.

ACTION: Notice of Horseracing Integrity and Safety Authority (HISA) 
proposed rule; correction.

-----------------------------------------------------------------------

SUMMARY: The Federal Trade Commission (``Commission'') published a 
document in the Federal Register of October 28, 2022, concerning the 
Anti-Doping and Medication Control proposed rule submitted by the 
Horseracing Integrity and Safety Authority. The Authority alerted the 
Commission that its submission contained an incorrect number. The 
Commission is issuing this correction to reflect the corrected number.

FOR FURTHER INFORMATION CONTACT: Austin King, Associate General Counsel 
for Rulemaking, 202-326-3166, [email protected], Office of the General 
Counsel, Federal Trade Commission, 600 Pennsylvania Avenue NW, 
Washington, DC 20580.

SUPPLEMENTARY INFORMATION:

Correction

    In FR Doc. 2022-22970 appearing at 87 FR 65292 in the Federal 
Register of Friday, October 28, 2022, in the table on page 65365, in 
the entry for ``ketoprofen,'' change the first sentence of the final 
column, which currently reads [4 ng/mL in serum or plasma.], to read [2 
ng/mL in serum or plasma.], which is the amount the Authority intended 
to submit but did not because of a typographical error.

    Dated: October 31, 2022.
April J. Tabor,
Secretary.
[FR Doc. 2022-24016 Filed 11-3-22; 8:45 am]
BILLING CODE 6750-01-P